Correction to: Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma

Correction to: Drugs (2020) 80:813–819 https://doi.org/10.1007/s40265-020-01302-2

Page 815, table 1, Efficacy of cemiplimab in adults with locally advanced or metastatic cutaneous squamous cell cancer in EMPOWER-CSCC 1: The title for the dosage on line 3, which previously read:

“Cemipliab 3 mg/kg once every 2 weeksb

should read:

“Cemiplimab 3 mg/kg once every 2 weeksb

Author information

Affiliations

Authors

Corresponding author

Correspondence to Arnold Lee.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, A., Duggan, S. & Deeks, E.D. Correction to: Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma. Drugs 80, 939 (2020). https://doi.org/10.1007/s40265-020-01332-w

Download citation